Accelerate Diagnostics Stock Price on November 8, 2024
| AXDX Stock | USD 1.51 0.07 4.43% |
Below is the normalized historical share price chart for Accelerate Diagnostics extending back to April 07, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Accelerate Diagnostics stands at 1.51, as last reported on the 10th of December, with the highest price reaching 1.63 and the lowest price hitting 1.48 during the day.
If you're considering investing in Accelerate Stock, it is important to understand the factors that can impact its price. Accelerate Diagnostics secures Sharpe Ratio (or Efficiency) of -0.0058, which signifies that the company had a -0.0058% return per unit of standard deviation over the last 3 months. Accelerate Diagnostics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Accelerate Diagnostics' risk adjusted performance of (0.01), and Mean Deviation of 3.01 to double-check the risk estimate we provide.
At this time, Accelerate Diagnostics' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 48.2 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (18.9 M). . Price To Sales Ratio is likely to drop to 3.85 in 2024. Price Earnings Ratio is likely to drop to -0.83 in 2024. Accelerate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of November 1996 | 200 Day MA 1.3629 | 50 Day MA 1.8034 | Beta 0.598 |
Accelerate |
Sharpe Ratio = -0.0058
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AXDX |
Estimated Market Risk
| 4.01 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Accelerate Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Accelerate Diagnostics by adding Accelerate Diagnostics to a well-diversified portfolio.
Enterprise Value Ebitda (1.10) | Price Sales 3.0811 | Shares Float 12.3 M | Wall Street Target Price 1.5 | Earnings Share (2.59) |
Accelerate Diagnostics Main Headline on 8th of November 2024
Accelerate Diagnostics Inc Q3 2024 Earnings Call Highlights ... by gurufocus.com
Net Sales Approximately 3 million for the quarter, compared to 3.3 million in the same period last year.Gross Margin Approximately 29 percent for the quarter, up
Accelerate Diagnostics Valuation on November 8, 2024
It is possible to determine the worth of Accelerate Diagnostics on a given historical date. On November 8, 2024 Accelerate was worth 1.9 at the beginning of the trading date compared to the closed value of 1.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Accelerate Diagnostics stock. Still, in general, we apply an absolute valuation method to find Accelerate Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Accelerate Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Accelerate Diagnostics' related companies.
| Open | High | Low | Close | Volume | |
| 2.03 | 2.03 | 1.95 | 1.97 | 88,563 | |
11/08/2024 | 1.90 | 1.95 | 1.78 | 1.83 | 63,879 |
| 1.81 | 1.92 | 1.77 | 1.91 | 72,919 |
| Backtest Accelerate Diagnostics | | | Accelerate Diagnostics History | | | Accelerate Diagnostics Valuation | Previous | Next |
Accelerate Diagnostics Trading Date Momentum on November 8, 2024
| On November 11 2024 Accelerate Diagnostics was traded for 1.91 at the closing time. The top price for the day was 1.92 and the lowest listed price was 1.77 . The trading volume for the day was 72.9 K. The trading history from November 11, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 4.37% . The overall trading delta against the current closing price is 1.09% . |
Accelerate Diagnostics Fundamentals Correlations and Trends
By evaluating Accelerate Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Accelerate Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Accelerate financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Accelerate Diagnostics Stock history
Accelerate Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Accelerate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Accelerate Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Accelerate Diagnostics stock prices may prove useful in developing a viable investing in Accelerate Diagnostics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.5 M | 13.1 M | |
| Net Loss | -56.2 M | -59.1 M |
Accelerate Diagnostics Stock Technical Analysis
Accelerate Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Accelerate Diagnostics Period Price Range
Low | December 10, 2024
| High |
0.00 | 0.00 |
Accelerate Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Accelerate Diagnostics December 10, 2024 Market Strength
Market strength indicators help investors to evaluate how Accelerate Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Accelerate Diagnostics shares will generate the highest return on investment. By undertsting and applying Accelerate Diagnostics stock market strength indicators, traders can identify Accelerate Diagnostics entry and exit signals to maximize returns
Accelerate Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Accelerate Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Accelerate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Accelerate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | 0.2684 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Accelerate Stock Analysis
When running Accelerate Diagnostics' price analysis, check to measure Accelerate Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelerate Diagnostics is operating at the current time. Most of Accelerate Diagnostics' value examination focuses on studying past and present price action to predict the probability of Accelerate Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelerate Diagnostics' price. Additionally, you may evaluate how the addition of Accelerate Diagnostics to your portfolios can decrease your overall portfolio volatility.